Dipeptidyl peptidase 4 inhibitors attenuates the decline of skeletal muscle mass in patients with type 2 diabetes

ConclusionsOur data suggest the potential of DPP4i to prevent the progressive loss of muscle mass with aging in patients with type 2 diabetes.

Source: Diabetes/Metabolism Research and Reviews - October 1, 2017 Category: Endocrinology Authors: Ryotaro Bouchi, Tatsuya Fukuda, Takato Takeuchi, Yujiro Nakano, Masanori Murakami, Isao Minami, Hajime Izumiyama, Koshi Hashimoto, Takanobu Yoshimoto, Yoshihiro Ogawa Tags: RESEARCH ARTICLE Source Type: research